Rapid Microbial Methods: The Need for Speed in Cell and Gene Therapies
When patients are administered biological treatments created from their own bodies - autologous r
When patients are administered biological treatments created from their own bodies - autologous r
By the year 2020, biopharmaceuticals are estimated to account for 50% of the most successful phar
Highly complex biologics such as proteins, monoclonal antibodies, and cell and gene therapies inc